TrialThe pharmacogenomics journal2016
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis.
S B Krintel et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this paperpooled ittrialcites it